#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Hypocalcaemia Aspergillus infection Postprandial hypoglycaemia Short stature homeobox gene mutation Propionic acidaemia Chemical burn Vulval cancer recurrent Plasma cell myeloma recurrent Cognitive disorder Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Selective polysaccharide antibody deficiency Nephrotic syndrome Haematological malignancy HER2 mutant non-small cell lung cancer Noonan syndrome More trials…

Learn about Rare Diseases

Vascular malformation – Life with Disease Lennox-Gastaut syndrome – Treatment Chondrosarcoma metastatic – Trials in Disease Marginal zone lymphoma – Trials in Disease Systemic mastocytosis – Basic Information Pleomorphic leiomyosarcoma – Life with Disease Basal cell naevus syndrome – Life with Disease KBG syndrome Hyperoxaluria Mucopolysaccharidosis – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Trandolapril Trimethoprim Ganciclovir Timolol Maleate Protein C Dobutamine Hydrochloride Padeliporfin Somapacitan Ag-946 Phosphate Quetiapine Cetrelimab Floxuridine Candesartan Cilexetil SODIUM IBANDRONATE Sunitinib Dazucorilant Paracetamol Ph. Eur. Gedatolisib Deutivacaftor Clobetasol Propionate More therapies…

Learn about Your Condition

Encephalitis autoimmune Laparotomy Post procedural oedema Cerebrovascular accident Laryngeal cancer stage II Alcoholic liver disease Bone marrow disorder Lymphoedema Inclusion body myositis Cataract Fibrosarcoma metastatic Hypervolaemia Leukocyte adhesion deficiency Procedural haemorrhage Psychogenic seizure More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Hormone receptor positive breast cancer

Study on the Effects of Durvalumab, Oleclumab, and Chemotherapy in Patients with Luminal B Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive breast cancer
Investigated Drugs:
Study of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Fluoroestradiol F-18
Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Abemaciclib

1 … 5 6 7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Hormone receptor positive breast cancer

Study on the Effects of Durvalumab, Oleclumab, and Chemotherapy in Patients with Luminal B Breast Cancer

Study of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations

Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies